Authors/Disclosures
|
Louise R. Rodino-Klapac
(Sarepta Therapeutics)
|
Ms. Rodino-Klapac has received personal compensation for serving as an employee of Sarepta Therapeutics, Inc.. Ms. Rodino-Klapac has received stock or an ownership interest from Sarepta Therapeutics. Ms. Rodino-Klapac has received intellectual property interests from a discovery or technology relating to health care. |
|
Christopher Shilling, MS
(Nationwide Children'S Hospital)
|
No disclosure on file |
|
Zarife F. Sahenk, MD, PhD, FÂ鶹´«Ã½Ó³»
(The Research Institute at Nationwide Childrens.org)
|
Dr. Sahenk has nothing to disclose. |
|
K. Reed Clark, PhD
|
No disclosure on file |
|
|
No disclosure on file |
|
Jerry R. Mendell, MD, FÂ鶹´«Ã½Ó³»
(The Research Institute at Nationwide Children's Hospital)
|
Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta Therapeutics . The institution of Dr. Mendell has received research support from Sarepta. |